Themis Medicare introduces novel opioid analgesic REMITHEM in India
Themis Medicare Ltd., a Mumbai-based pharmaceutical company with a 50-year legacy, has announced the launch of REMITHEM, a novel opioid injectable analgesic, in the Indian ... Read More
Themis Medicare gets DGCI approval for narcotic painkiller REMITHEM
Themis Medicare has been granted approval from the Drug Controller General of India (DCGI) for importing and commercialization of Remifentanil 1 mg/2mg Powder for Concentrate ... Read More
Themis Medicare, NFL Biosciences partner on smoking cessation candidate NFL-101
Indian pharmaceutical company Themis Medicare has joined hands with French biotech company NFL Biosciences to develop NFL-101, a drug candidate for smoking cessation for the ... Read More